1. Home
  2. VNRX vs MATH Comparison

VNRX vs MATH Comparison

Compare VNRX & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • MATH
  • Stock Information
  • Founded
  • VNRX N/A
  • MATH 2015
  • Country
  • VNRX United States
  • MATH Hong Kong
  • Employees
  • VNRX N/A
  • MATH N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MATH Finance/Investors Services
  • Sector
  • VNRX Health Care
  • MATH Finance
  • Exchange
  • VNRX Nasdaq
  • MATH Nasdaq
  • Market Cap
  • VNRX 52.4M
  • MATH 60.8M
  • IPO Year
  • VNRX N/A
  • MATH N/A
  • Fundamental
  • Price
  • VNRX $0.66
  • MATH $3.60
  • Analyst Decision
  • VNRX Strong Buy
  • MATH
  • Analyst Count
  • VNRX 5
  • MATH 0
  • Target Price
  • VNRX $3.88
  • MATH N/A
  • AVG Volume (30 Days)
  • VNRX 319.2K
  • MATH 197.9K
  • Earning Date
  • VNRX 08-13-2025
  • MATH 08-26-2025
  • Dividend Yield
  • VNRX N/A
  • MATH N/A
  • EPS Growth
  • VNRX N/A
  • MATH N/A
  • EPS
  • VNRX N/A
  • MATH 0.17
  • Revenue
  • VNRX $1,308,361.00
  • MATH $31,399,049.00
  • Revenue This Year
  • VNRX $563.72
  • MATH N/A
  • Revenue Next Year
  • VNRX $160.43
  • MATH N/A
  • P/E Ratio
  • VNRX N/A
  • MATH $22.72
  • Revenue Growth
  • VNRX 64.16
  • MATH 291.58
  • 52 Week Low
  • VNRX $0.40
  • MATH $0.80
  • 52 Week High
  • VNRX $0.94
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 47.94
  • MATH 61.32
  • Support Level
  • VNRX $0.62
  • MATH $3.55
  • Resistance Level
  • VNRX $0.76
  • MATH $3.97
  • Average True Range (ATR)
  • VNRX 0.08
  • MATH 0.32
  • MACD
  • VNRX -0.02
  • MATH 0.03
  • Stochastic Oscillator
  • VNRX 12.47
  • MATH 83.49

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: